New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:37 EDTHTBXHeat Biologics to form CAB with immunotherapy, oncology experts
Heat Biologics announced the creation of a Clinical Advisory Board, or CAB, to actively design and guide its clinical trials and the appointment of four leading oncologists to serve on this board. Justin Stebbing, M.D., Ph.D. will serve as Chairman of the CAB and chief medical advisor to Heat. The CAB will work hand-in-hand with Heat's clinical team, led by Melissa Price, Ph.D., Vice President of Clinical and Regulatory Affairs. Dr. Stebbing will serve as lead advisor on the company's clinical trials.
News For HTBX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
17:05 EDTHTBXHeat Biologics files $50M mixed securities shelf
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use